Protease-activated receptors: sentries for inflammation?
- 1 March 2000
- journal article
- review article
- Published by Elsevier BV in Trends in Pharmacological Sciences
- Vol. 21 (3), 103-108
- https://doi.org/10.1016/s0165-6147(99)01440-6
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Evidence for Selective Effects of Chronic Hypertension on Cerebral Artery Vasodilatation to Protease-Activated Receptor-2 ActivationStroke, 1999
- Pro‐ and anti‐inflammatory actions of thrombin: a distinct role for proteinase‐activated receptor‐1 (PAR1)British Journal of Pharmacology, 1999
- Proteolytically Activated Receptor-3 A Member of an Emerging Gene Family of Protease Receptors Expressed on Vascular Endothelial Cells and PlateletsTrends in Cardiovascular Medicine, 1999
- Bronchoconstrictor effect of thrombin and thrombin receptor activating peptide in guinea‐pigs in vivoBritish Journal of Pharmacology, 1999
- Endothelium‐dependent contractile actions of proteinase‐activated receptor‐2‐activating peptides in human umbilical vein: release of a contracting factor via a novel receptorBritish Journal of Pharmacology, 1998
- Increased vascular permeability by a specific agonist of protease‐activated receptor‐2 in rat hindpawBritish Journal of Pharmacology, 1998
- Endothelium-dependent and -independent responses to protease-activated receptor-2 (PAR-2) activation in mouse isolated renal arteriesBritish Journal of Pharmacology, 1998
- Expression of Trypsin by Epithelial Cells of Various Tissues, Leukocytes, and Neurons in Human and MouseThe American Journal of Pathology, 1998
- Activation of Protease-Activated Receptor-2 (PAR-2) Elicits Nitric Oxide–Dependent Dilatation of the Basilar Artery In VivoStroke, 1998
- Endogenous mediators that inhibit the leukocyte– endothelium interactionTrends in Pharmacological Sciences, 1997